State Key Laboratory of Genetic Engineering, Department of Pharmaceutical Sciences, School of Life Sciences, Fudan University, Shanghai 200433, China.
Biomaterials. 2010 May;31(13):3657-66. doi: 10.1016/j.biomaterials.2010.01.065. Epub 2010 Feb 6.
To elucidate the effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles (NPs), rhodamine B (RhB) labeled carboxymethyl chitosan grafted NPs (RhB-CMCNP) and chitosan hydrochloride grafted NPs (RhB-CHNP) were developed as the model negatively and positively charged polymeric NPs, respectively. These NPs owned well defined particle sizes (150-500 nm) and Zeta potentials (-40 mV - +35 mV). FITC labeled protamine sulfate (FITC-PS) loaded RhB-CMCNP and camptothecin (CPT) loaded RhB-CHNP with high encapsulation efficiency were prepared. The fluorescence stability in plasma and towards I(-) was investigated, and the result indicated it was sufficient for qualitative and quantitative analysis. NPs with high surface charge and large particle size were phagocytized more efficiently by murine macrophage. Slight particle size and surface charge differences and different cell lines had significant implications in the cellular uptake of NPs, and various mechanisms were involved in the uptake process. In vivo biodistribution suggested that NPs with slight negative charges and particle size of 150 nm were tended to accumulate in tumor more efficiently. These results could serve as a guideline in the rational design of drug nanocarriers with maximized therapeutic efficacy and predictable in vivo properties, in which the control of particle size and surface charge was of significance.
为了阐明颗粒大小和表面电荷对聚合物纳米粒子(NPs)细胞摄取和体内分布的影响,分别制备了带负电荷和带正电荷的聚合物纳米粒子模型:罗丹明 B(RhB)标记的羧甲基壳聚糖接枝 NPs(RhB-CMCNP)和壳聚糖盐酸盐接枝 NPs(RhB-CHNP)。这些 NPs 的粒径(150-500nm)和 Zeta 电位(-40mV 至+35mV)均具有良好的定义。制备了具有高包封效率的 FITC 标记硫酸鱼精蛋白(FITC-PS)负载 RhB-CMCNP 和喜树碱(CPT)负载 RhB-CHNP。研究了它们在血浆中的荧光稳定性和对 I(-)的稳定性,结果表明它们足以进行定性和定量分析。具有高表面电荷和大粒径的 NPs 更有效地被鼠巨噬细胞吞噬。略微的粒径和表面电荷差异以及不同的细胞系对 NPs 的细胞摄取有重要影响,并且涉及多种摄取机制。体内分布表明,带轻微负电荷且粒径为 150nm 的 NPs 更倾向于更有效地在肿瘤中积累。这些结果可以为药物纳米载体的合理设计提供指导,以实现最大的治疗效果和可预测的体内特性,其中控制颗粒大小和表面电荷具有重要意义。